Factors affecting endotoxin removal from recombinant therapeutic proteins by anion exchange chromatography

Protein Expression and Purification

Volumn 64, Issue 1, 2009, Pages 76-81

  Chen, Rishard H ^a   Huang, Chung Jr ^a   Newton, Brian S ^b   Ritter, Gerd ^b   Old, Lloyd J ^b   Batt, Carl A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

Endotoxin; Melan A; NY ESO 1; Purification; Pyrogen; Scale up

Indexed keywords

CTAG1B PROTEIN, HUMAN; ENDOTOXIN; MART1 ANTIGEN; MEMBRANE PROTEIN; PROTEIN; RECOMBINANT PROTEIN; REPRESSOR PROTEIN; SYNOVIAL SARCOMA X BREAKPOINT PROTEINS; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; CHEMISTRY; ELECTRIC CONDUCTIVITY; ION EXCHANGE CHROMATOGRAPHY; ISOELECTRIC POINT; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PH; PROTEIN BINDING;

ANTIGENS, NEOPLASM; CHROMATOGRAPHY, ION EXCHANGE; ELECTRIC CONDUCTIVITY; ENDOTOXINS; HYDROGEN-ION CONCENTRATION; ISOELECTRIC POINT; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROTEIN BINDING; PROTEINS; RECOMBINANT PROTEINS; REPRESSOR PROTEINS;

BACTERIA (MICROORGANISMS);

EID: 57649104748     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.10.006     Document Type: Article

References (32)

1. Sorensen H., and Mortensen K. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol. 115 (2005) 113-128
2. Lee S. High cell-density cultures of Escherichia coli. Trends Biotechnol. 14 (1996) 98-105
3. Babaeipour V., Shojaosadati S., Robatjazi S., Khalizadeh R., and Magsoudi N. Over-production of human interferon-γ by HCDC of recombinant Escherichia coli. Process Biochem. 42 (2007) 112-117
4. Berthold W., and Walter J. Protein purification: aspects of processes for pharmaceutical products. Biologicals 22 (1994) 135-150
5. Seid R., and Sadoff J. Preparation and characterization of detoxified lipopolysaccharide-protein conjugates. J. Biol. Chem. 256 (1981) 7305-7310
6. Rietschel E., Kirikae T., Schade F., Mamat U., Schmidt G., Loppnow H., Ulmer A., Zähringer U., Seydel U., Di Padova F., Schreier M., and Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8 (1994) 217-225
7. Morrison D., and Ulevitch R. The effects of bacterial endotoxins on host mediation systems: a review. Am. J. Pathol. 93 (1978) 526-617
8. Van Leeuwen P., Boermeester M., and Houdijk A. Clinical significance of translocation. Gut 35 (1994) S28-S34
9. United States Pharmacopoeia-National Formulary, (2007) USP30-NF25.
10. Petsch D., and Anspach F. Endotoxin removal from protein solutions. J. Biotechnol. 76 (2000) 97-119
11. Reichelt P., Schwartz C., and Donzeau M. Single step protocol to purify recombinant proteins with low endotoxin contents. Prot. Expr. Purif. 46 (2006) 483-488
12. Wilson M., Haggart C., Gallagher S., and Walsh D. Removal of tightly bound endotoxin from biological products. J. Biotechnol. 88 (2001) 67-75
13. Pearson F. Pyrogens: Endotoxins, LAL Testing, and Depyrogenation (1985), Marcel Dekker Inc., New York
14. Mitzner S., Schneidewind J., Falkenhagen D., Loth F., and Klinkmann H. Extracorporeal endotoxin removal by immobilized polyethyleneimine. Artif. Organs 17 (1993) 775-781
15. Liu S., Tobias R., McClure S., Styba G., Shi Q., and Jackowski G. Removal of endotoxins from recombinant protein preparations. Clin. Biochem. 30 (1997) 455-463
16. Fang H., Wei J., and Yu Y. In vivo studies of endotoxin removal by lysine-cellulose adsorbents. Biomaterials 25 (2004) 5433-5440
17. Hou K., and Zaniewski R. Endotoxin removal by anion-exchange polymeric matrix. Biotechnol. Bioeng. 12 (1990) 315-324
18. Gnjatic S., Nishikawa H., Jungbluth A., Güre A., Ritter G., Jäger E., Knuth A., Chen Y., and Old L. NY-ESO-1: review of an immunogenic tumor antigen. Adv. Cancer Res. 95 (2006) 1-30
19. Romero P., Valmori D., Pittet M., Zippelius A., Rimoldi D., Levy F., Dutoit V., Ayyoub M., Rubio-Godoy V., Michielin O., Guillaume P., Batard P., Luescher I., Lejeune F., Lienard D., Rufer N., Dietrich P., Speiser D., and Cerottini J. Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol. Rev. 188 (2002) 81-96
20. Sahin U., Türeci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., Luo G., Schobert I., and Pfreundschuh M. Human neoplasms elicit multiple specific immune-responses in the autologous host. Proc. Natl. Acad. Sci. USA 92 (1995) 11810-11813
21. Miroux B., and Walker J. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J. Mol. Biol. 260 (1996) 289-298
22. Huang C., Chen R., Vannelli T., Lee F., Ritter E., Ritter G., Old L., and Batt C. Expression and purification of the cancer antigen SSX2: a potential cancer vaccine. Prot. Expr. Purif. 56 (2007) 212-219
23. Robbins J., and Taylor K. Optimization of Escherichia coli growth by controlled addition of glucose. Biotechnol. Bioeng. 34 (1989) 1289-1294
24. Shalliker R., Broyles B., and Guiochon G. Physical evidence of two wall effects in liquid chromatography. J. Chromatogr. A 888 (2000) 1-12
25. Kleman G., and Strohl W. Developments in high cell density and high productivity microbial fermentation. Curr. Opin. Biotechnol. 5 (1994) 180-186
26. Murphy R., Green S., Ritter G., Cohen L., Ryan D., Woods W., Rubira M., Cebon J., Davis I., Sjolander A., Kypridis A., Kalnins H., McNamara M., Moloney M., Ackland J., Cartwright G., Rood J., Dumsday G., Healy K., and Maher D. Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions. Prep. Biochem. Biotechnol. 35 (2005) 119-134
27. Kluger M., Singer R., and Eiger S. Polymyxin B use does not ensure endotoxin-free solution. J. Immunol. Methods 83 (1985) 201-207
28. Zimmerman T., Frere C., Satzger M., Raba M., Weisbach M., Dohn K., Popp A., and Donzeau M. Simultaneous metal chelate affinity purification and endotoxin clearance of recombinant antibody fragments. J. Immunol. Methods 314 (2006) 67-73
29. Anspach F., and Hilbeck O. Removal of endotoxins by affinity sorbents. J. Chromatogr. A 711 (1995) 81-92
30. Ding J., and Ho B. A new era in pyrogen testing. Trends Biotechnol. 19 (2001) 277-281
31. Rathore A., and Velayudhan A. Guidelines for optimization and scale-up in preparative chromatography. Biopharm. Int. 16 (2003) 34-42
32. Kang Y., and Luo R. Effects of ionic strength and pH on endotoxin removal efficiency and protein recovery in an affinity chromatography. Process Biochem. 36 (2000) 85-92